Theobromine kinetics and metabolic disposition

Area of Science:

• Pharmacokinetics
• Drug Metabolism
• Analytical Chemistry

Background:

• Theobromine, a methylxanthine found in cocoa, has potential health benefits but its metabolic fate requires detailed understanding.
• Limited data exists on the quantitative metabolism and excretion of theobromine in humans following oral administration.

Purpose of the Study:

• To investigate the metabolism and pharmacokinetics of a single oral dose of 8-14C-theobromine in healthy adult males.
• To identify and quantify theobromine metabolites in plasma and urine.
• To determine the urinary excretion patterns and calculate metabolic rate constants.

Main Methods:

• Administration of a single oral dose of 8-14C-theobromine (30 microCi) with theobromine sodium acetate (10 mg/kg) to six healthy male volunteers.
• Collection of plasma and urine samples over time.
• Analysis of metabolites using High-Performance Liquid Chromatography (HPLC) and thin-layer chromatography coupled with radiography.
• Quantification of radioactivity and metabolite identification.
• Application of the sigma-minus method to urinary excretion data for kinetic analysis.

Main Results:

• Theobromine was the predominant compound detected in plasma.
• Identified urinary metabolites included theobromine, 7-methylxanthine, 7-methyluric acid, 3-methylxanthine, 6-amino-5[N-methylformylamino]-1-methyluracil, and 3,7-dimethyluric acid.
• All administered radioactivity was recovered in urine, with no polar metabolites detected.
• Apparent first-order rate constants for the production of major urinary metabolites were calculated.

Conclusions:

• Theobromine is extensively metabolized in humans, with the primary route of excretion being via urine.
• The identified metabolites represent the major metabolic pathways of theobromine in the human body.
• The pharmacokinetic analysis provides valuable data for understanding the disposition of theobromine.